Mgc Pharmaceuticals Stock Five Year Return
MGC Pharmaceuticals fundamentals help investors to digest information that contributes to MGC Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of MGC OTC Stock. The fundamental analysis module provides a way to measure MGC Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MGC Pharmaceuticals otc stock.
MGC |
MGC Pharmaceuticals OTC Stock Five Year Return Analysis
MGC Pharmaceuticals' Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
CompetitionAccording to the company disclosure, MGC Pharmaceuticals has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
All Next | Launch Module |
MGC Fundamentals
Return On Equity | -2.19 | |||
Return On Asset | -0.45 | |||
Operating Margin | (3.28) % | |||
Current Valuation | 24.97 M | |||
Shares Outstanding | 2.87 B | |||
Shares Owned By Insiders | 9.10 % | |||
Shares Owned By Institutions | 6.12 % | |||
Price To Book | 5.69 X | |||
Price To Sales | 5.81 X | |||
Revenue | 4.65 M | |||
Gross Profit | 562.87 K | |||
EBITDA | (16.44 M) | |||
Net Income | (20.35 M) | |||
Cash And Equivalents | 1.89 M | |||
Total Debt | 4.35 M | |||
Debt To Equity | 0.84 % | |||
Current Ratio | 0.84 X | |||
Book Value Per Share | 0 X | |||
Cash Flow From Operations | (12.16 M) | |||
Earnings Per Share | (0.01) X | |||
Number Of Employees | 16 | |||
Beta | 1.23 | |||
Market Capitalization | 17.2 M | |||
Total Asset | 22.6 M | |||
Z Score | 1.8 | |||
Net Asset | 22.6 M |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in MGC OTC Stock
If you are still planning to invest in MGC Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MGC Pharmaceuticals' history and understand the potential risks before investing.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |